HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low level rubella immunity detected by ELISA and specific lymphocyte transformation.

Abstract
The level of humoral and cell mediated immunity in persons with low or undetectable hemagglutination-inhibition (HAI) rubella titers was investigated by ELISA, IgG presence in sucrose gradient separated serum fractions and lymphocyte transformation. The study population consisted of persons with stated history of natural rubella infection and rubella vaccinees. Persons with natural rubella infection and HAI titers of 1:8 or +/- 1:8 (i.e., incomplete HAI at serum dilution of 1:8) were all ELISA positive and the stimulation index (SI) of specific lymphocyte transformation was higher than 2.5. Among the 20 persons with HAI titers of < 1:8, 8 were found to be ELISA positive and their SI was also > 2 and IgG was detected in their serum. Rubella vaccinees with HAI titers of 1:8 or +/- 1:8 were likewise ELISA positive. Their SI was lower: none higher than 3, but none lower than 1.5. Among 23 HAI negative vaccinees, 14 were found ELISA positive. This serum fraction contained IgG and the SI was > 1.5. It appears that ELISA test is able to detect antibodies where the HAI test fails. The positive outcome of ELISA test in this case was confirmed by the presence of IgG in serum fractions and by the lymphocyte response to rubella specific stimulation.
AuthorsE Buimovici-Klein, A J O'Beirne, S J Millian, L Z Cooper
JournalArchives of virology (Arch Virol) Vol. 66 Issue 4 Pg. 321-7 ( 1980) ISSN: 0304-8608 [Print] Austria
PMID7447708 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Viral
  • Rubella Vaccine
Topics
  • Antibodies, Viral (analysis)
  • Enzyme-Linked Immunosorbent Assay
  • Hemagglutination Inhibition Tests
  • Humans
  • Lymphocyte Activation
  • Rubella (immunology)
  • Rubella Vaccine (immunology)
  • Rubella virus (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: